pneumonia
TRANSCRIPT
![Page 1: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/1.jpg)
PNEUMONIADr. Firoz A Hakkim
MBBS MDPULMONARY MEDICINE
![Page 2: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/2.jpg)
![Page 3: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/3.jpg)
• Pneumonia is an infection of the pulmonary parenchyma.
• caused by acute infection, usually bacterial, characterized by clinical and/or radiographic signs of consolidation of a part or parts of one or both lungs.
![Page 4: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/4.jpg)
![Page 5: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/5.jpg)
![Page 6: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/6.jpg)
![Page 7: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/7.jpg)
• ‘Lobar pneumonia’ is a radiological and pathological term referring to homogeneous consolidation of one or more lung lobes, often with associated pleural inflammation.
• Bronchopneumonia’ refers to more patchy alveolar consolidation associated with bronchial and bronchiolar inflammation, often affecting both lower lobes.
![Page 8: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/8.jpg)
![Page 9: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/9.jpg)
PATHOPHYSIOLOGY
• proliferation of microbial pathogens at the alveolar level and the host’s response to those pathogens.
• aspiration from the oropharynx
• Pathogens are inhaled as contaminated droplets.
![Page 10: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/10.jpg)
• hematogenous spread (e.g., from tricuspid endocarditis) or by contiguous extension from an infected pleural or mediastinal space.
• Once engulfed, the pathogens—even if they are not killed by macrophages—are eliminated via either the mucociliary elevator or the lymphatics and no longer represent an infectious challenge.
• Only when the capacity of the alveolar macrophages to ingest or kill the microorganisms is exceeded does clinical pneumonia become manifest.
![Page 11: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/11.jpg)
• Alveolar macrophages initiate the inflammatory response to bolster lower respiratory tract defenses.
• Inflammatory mediators released by macrophages and the newly recruited neutrophils create an alveolar capillary leak.
• The capillary leak results in a radiographic infiltrate and rales detectable on auscultation, and hypoxemia results from alveolar filling.
![Page 12: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/12.jpg)
PATHOLOGY
• Edema• red hepatization• gray hepatization• resolution
![Page 13: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/13.jpg)
• Edema- with the presence of a proteinaceous exudate - and often of bacteria—in the alveoli.
• This phase is rarely evident in clinical or autopsy specimens because it is so rapidly followed by a red hepatization phase.
![Page 14: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/14.jpg)
• red hepatization - presence of erythrocytes in the cellular intraalveolar exudate gives this second stage its name, but neutrophils are also present and are important from the standpoint of host defense.
• Bacteria are occasionally seen in cultures of alveolar specimens collected during this phase.
![Page 15: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/15.jpg)
• gray hepatization - no new erythrocytes are extravasating, and those already present have been lysed and degraded.
• The neutrophil is the predominant cell, fibrin deposition is abundant, and bacteria have disappeared.
• This phase corresponds with successful containment of the infection and improvement in gas exchange.
![Page 16: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/16.jpg)
• Resolution - the macrophage is the dominant cell type in the alveolar space, and the debris of neutrophils, bacteria, and fibrin has been cleared, as has the inflammatory response.
![Page 17: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/17.jpg)
COMMUNITY-ACQUIRED PNEUMONIA
• extensive list of potential etiologic agents in CAP includes bacteria, fungi, viruses, and protozoa.
![Page 18: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/18.jpg)
• Clinical features – patient is frequently febrile, with a tachycardic response, and may have chills and/or sweats and cough that is either nonproductive or productive of mucoid, purulent, or blood-tinged sputum.
• Pleuritic chest pain, gastrointestinal symptoms• increased respiratory rate, use of accessory
muscles of respiration.
![Page 19: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/19.jpg)
![Page 20: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/20.jpg)
• Palpation may reveal increased or decreased tactile fremitus
• percussion note can vary from dull to flat, reflecting underlying consolidated lung and pleural fluid.
• Crackles, bronchial breath sounds, and possibly a pleural friction rub may be heard on auscultation.
![Page 21: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/21.jpg)
![Page 22: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/22.jpg)
![Page 23: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/23.jpg)
![Page 24: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/24.jpg)
![Page 25: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/25.jpg)
![Page 26: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/26.jpg)
Pa view
Lateral view
![Page 27: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/27.jpg)
Management
• Oxygen should be administered to all patients with tachypnoea, hypoxaemia, hypotension or acidosis, with the aim of maintaining the PaO2 at or above 8 kPa (60 mmHg) or the SaO2 at or above 92%.
![Page 28: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/28.jpg)
![Page 29: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/29.jpg)
• Intravenous fluids – severe illness, older patients and those who are vomiting. Inotropic support may be required in patients with shock.
![Page 30: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/30.jpg)
![Page 31: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/31.jpg)
Discharge and follow-up
• depends on their home circumstances and the likelihood of complications.
• Clinical review should be arranged around 6 weeks later and a chest X-ray obtained if there are persistent symptoms, physical signs or reasons to suspect underlying malignancy.
![Page 32: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/32.jpg)
Prevention
• Current smokers should be advised to stop.• Influenza and pneumococcal vaccination.
• Tackling malnourishment and indoor air pollution, and encouraging immunisation against measles, pertussis and Haemophilus influenzae type b are particularly important in children.
![Page 33: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/33.jpg)
![Page 34: Pneumonia](https://reader036.vdocument.in/reader036/viewer/2022070600/58b894671a28ab3e3a8b652b/html5/thumbnails/34.jpg)
THANK YOU